TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary Efficacy

NCT07514065 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration-Resistant Prostate Cancer Patients

Interventions

DRUG: Treatment arm: TSL2109 capsules。Oral administration。

Sponsor

Tasly Pharmaceutical Group Co., Ltd